PRB2 and autoimmune polyendocrinopathy: Importantly, the combined positivity of anti-β2GPI-D1 and anti-PS/PT demonstrates a high positive predictive value for APS diagnosis and effectively identifies patients at higher thrombotic risk (18, 22–24).